Comparative efficacy between atorvastatin and rosuvastatin in the prevention of cardiovascular disease recurrence

BACKGROUND: There is no randomized clinical trials with recurrence of atherosclerotic cardiovascular disease (ASCVD) as a major outcome with rosuvastatin. In order to analyze potential differences in the clinical response to atorvastatin and rosuvastatin in secondary ASCVD prevention, we have analyz...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Lipids Health Dis
Autori principali: Perez-Calahorra, Sofía, Laclaustra, Martin, Marco-Benedi, Victoria, Pinto, Xavier, Sanchez-Hernandez, Rosa M., Plana, Núria, Ortega, Emilio, Fuentes, Francisco, Civeira, Fernando
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2019
Soggetti:
Short Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6905000/
https://ncbi.nlm.nih.gov/pubmed/31829197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12944-019-1153-x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi